Page last updated: 2024-08-22

fluorescein-5-isothiocyanate and Carcinoma, Pancreatic Ductal

fluorescein-5-isothiocyanate has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabral, H; Iwata, C; Kano, MR; Miyazono, K; Morishita, Y; Sakai, S; Tanaka, HY1

Other Studies

1 other study(ies) available for fluorescein-5-isothiocyanate and Carcinoma, Pancreatic Ductal

ArticleYear
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 05-28, Volume: 230

    Topics: Albumin-Bound Paclitaxel; Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Collagen Type I; Dextrans; Disease Models, Animal; Fibroblast Growth Factor 2; Fibrosis; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydroxyproline; Male; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; RNA, Messenger; Xenograft Model Antitumor Assays

2016